Tea tree methylated catechin synthetase CsFAOMT2, coding gene and application thereof

By cloning and expressing the tea plant O-methyltransferase CsFAOMT2 gene, EGCG was catalyzed to convert into EGCG3″Me and EGCG4″Me, solving a problem in tea plant breeding and increasing the content of health-functional components in tea.

CN118956803APending Publication Date: 2024-11-15TEA RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411245068.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2022-11-22
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing technologies are insufficient to efficiently catalyze the conversion of EGCG to EGCG3″Me and EGCG4″Me in tea plants. Traditional breeding methods are time-consuming and difficult, and key OMTs involved in specific O-methyl groups at the 3″ and 4″ positions have not been identified.

Method used

A novel O-methyltransferase gene, CsFAOMT2, from tea plants was cloned and expressed. Recombinant proteins were prepared using recombinant engineered bacteria and used to catalyze the conversion of EGCG into EGCG3″Me and EGCG4″Me.

Benefits of technology

It achieves efficient catalytic conversion of EGCG to EGCG3″Me and EGCG4″Me, promotes the breeding of superior tea varieties, increases the content of methylated catechins in tea, and enhances the health functions of tea.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118956803A_ABST
    Figure CN118956803A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of bioengineering, and relates to tea tree methylated catechin synthetase CsFAOMT2, a coding gene and application of the tea tree methylated catechin synthetase CsFAOMT2. Related genes are found through a series of methods and technologies, recombinant engineering bacteria are constructed, recombinant protein is obtained, and the gene of O-methyltransferase CsFAOMT2 related to catechin synthesis in tea trees is verified by means of an enzyme reaction method. The O-methyltransferase gene capable of catalyzing methylated catechin synthesis is obtained, and the application value of the O-methyltransferase gene in breeding and synthetic biology of good varieties of tea trees is achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biotechnology, and specifically relates to tea tree methylated catechin synthase CsFAOMT2, encoding gene and application thereof. This application is a divisional application, the original application number is CN2022114635851, and the application date is November 22, 2022. Background Art

[0002] Tea is one of the most consumed beverages in the world. Tea's popularity lies in its unique flavor and health benefits, which are conferred by a variety of bioactive compounds in tea leaves, such as caffeine and catechins. Catechins, which account for more than 12% of the dry weight of tea, are a class of bioactive polyphenols, of which (-)-epigallocatechin-3-gallate (EGCG) is the most abundant component. Extensive studies have confirmed the health-promoting effects of EGCG, including anti-cancer, anti-inflammatory and cardioprotective effects. However, the therapeutic effects of EGCG are greatly reduced due to its instability in the neutral to alkaline conditions of the intestine. In addition, the highly polar nature of the structure also makes it difficult to penetrate the intestinal wall, further reducing its bioavailability in the human body.

[0003] O-methylated EGCG is a series of methylated derivatives formed by modifying the phenolic hydroxyl group on the benzene ring of EGCG with a methyl group. In tea plants, natural methylation mainly occurs at the 3″ and 4″ positions of EGCG to produce (-)-epigallocatechin-3-O-(3-O-methyl)-gallate (EGCG3″Me) and (-)-epigallocatechin-3-O-(4-O-methyl)-gallate (EGCG4″Me). In previous studies, the inventors investigated the levels of EGCG3″Me and EGCG4″Me in 27 tea germplasm resources with different genetic backgrounds, and detected EGCG3″Me in about half of the germplasm resources, and EGCG4″Me was only detected in 3 resources. Clinical trials have shown that tea containing EGCG3″Me (Benifuki) has stronger anti-allergic and anti-hypertensive effects than tea without EGCG3″Me (Yabukita).

[0004] Although tea plants are rich in EGCG, tea plants that are naturally rich in methylated catechins are rare. Tea plants have a long juvenile period, which makes it challenging and time-consuming to develop new varieties with high methylated catechins through traditional breeding methods. Previous studies have shown that O-methyltransferases (OMTs) can catalyze the formation of methylated catechins. In fact, caffeoyl-CoA-O-methyltransferase (CCoAOMT) has been cloned from tea plants. However, in vitro enzymatic reactions using recombinant CCoAOMT produced a variety of methylated catechins, including EGCG3″Me, EGCG4″Me, (-)-epigallocatechin-3-O-(3,5-O-dimethyl)-gallate, and (-)-3-O-methyl-epigallocatechin-3-O-(3,5-O-dimethyl)-gallate, which is inconsistent with the fact that the main O-methylated EGCG detected in tea plants is EGCG3″Me and / or EGCG4″Me. This suggests that the key OMTs involved in the specific O-methyl groups at the 3″ and 4″ positions remain unidentified. Summary of the invention

[0005] In view of the problems existing in the prior art, the purpose of the present invention is to design and provide a technical solution for tea tree methylated catechin synthase CsFAOMT2, encoding gene and application thereof.

[0006] The present invention specifically adopts the following technical solutions:

[0007] The first aspect of the present invention provides a methylated catechin synthase CsFAOMT2, the amino acid sequence of which is shown in SEQ ID No. 4;

[0008] Or an amino acid sequence having the same protein function as the amino acid sequence shown in SEQ ID NO.4 after substitution and / or deletion and / or addition of several amino acid residues;

[0009] Or an amino acid sequence derived from the amino acid sequence shown in SEQ ID No. 4, having more than 98% homology and having the same protein function.

[0010] The second aspect of the present invention provides a gene encoding the above-mentioned methylated catechin synthase CsFAOMT2, characterized in that its nucleotide sequence is shown in SEQ ID No.3;

[0011] or a DNA sequence that hybridizes with the DNA sequence shown in SEQ ID No.3 and encodes a protein with the same function;

[0012] Or a DNA molecule having more than 95% homology with the DNA sequence shown in SEQ ID No.3 and encoding a protein with the same function.

[0013] The third aspect of the present invention provides the use of the above-mentioned methylated catechin synthase CsFAOMT2 as an O-methyltransferase.

[0014] The fourth aspect of the present invention provides the use of the above-mentioned methylated catechin synthase CsFAOMT2 in the breeding of superior tea varieties.

[0015] The fifth aspect of the present invention provides the use of the above-mentioned methylated catechin synthase CsFAOMT2 in catalyzing the conversion of EGCG into EGCG3"Me and EGCG4"Me.

[0016] The present invention has the following beneficial effects:

[0017] The invention describes an O-methyltransferase gene capable of catalyzing the synthesis of methylated catechins, and its application value in the breeding of superior tea tree varieties and tea processing.

[0018] The invention obtains recombinant protein by constructing recombinant engineering bacteria, and verifies the gene encoding O-methyltransferase CsFAOMT2 in tea tree by using the recombinant protein of genetic engineering bacteria as catalytic enzyme by means of enzyme reaction method. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 Identification of key candidate genes involved in the biosynthesis of O-methylated catechins in tea plants. (a) Biosynthetic pathways of major O-methylated catechins (EGCG3″Me and EGCG4″Me). (b) Chromosomal distribution based on the Euclidean distance (ED) values ​​of SNPs and InDels. (c) Phylogenetic tree analysis of O-methyltransferases.

[0020] Figure 2 Amino acid sequence differences between CsFAOMT1 and CsFAOMT2.

[0021] Figure 3 SDS-PAGE analysis of empty vector (EV), CsFAOMT1, and CsFAOTT2 recombinant proteins.

[0022] Figure 4 Total ion chromatogram and MS of reaction products from in vitro O-methyltransferase activity assay 2 Ion fragmentation. The in vitro reaction product of recombinant CsFAOMT1 and CsFAOMT2, (-)-epigallocatechin gallate (1) was used as the substrate, and the empty vector (EV) was used as the control. 2, (-)-epigallocatechin-3-O-(4-O-methyl)-gallate; 3, (-)-epigallocatechin-3-O-(3-O-methyl)-gallate. ESI + model. DETAILED DESCRIPTION

[0023] The present invention is further described in detail below in conjunction with specific examples, which are intended to explain the present invention rather than to limit it.

[0024] In order to make the purpose, technical scheme and advantages of the present invention more clear, the present invention is further described in detail below in conjunction with the examples. The equipment and reagents used in each embodiment and test example can be obtained from commercial sources unless otherwise specified. The specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.

[0025] The present invention relates to two methylated catechin synthase genes and their encoded proteins, which are named CsFAOMT1 and CsFAOMT2 respectively. The nucleotide sequence of CsFAOMT1 gene is shown in SEQ ID No.1, and the amino acid sequence is shown in SEQ ID No.2; the nucleotide sequence of CsFAOMT2 gene is shown in SEQ ID No.3, and the amino acid sequence is shown in SEQ ID No.4.

[0026] The specific sequence of SEQ ID No.1 is:

[0027]

[0028]

[0029] The specific sequence of SEQ ID No.2 is:

[0030]

[0031] The specific sequence of SEQ ID No.3 is:

[0032]

[0033] The specific sequence of SEQ ID No.4 is:

[0034] MADNIVLKTILKSEALQKYIWDTSAYPREHEQLKRLRDATFKKYGDRAVMGVPPDEGLFLSMLLKLMNAKKTLEIGVFTGYSLLTTALALPHDGQIVAIDPNREAFEVGLPCIQKAGV EHKINFIESDAISILNEMLSDEGKLKMEFDFVLVDADKPNYINYHEQAIKLVKVGGVIAYDNTLWRGLVVSKEEEVPERFRANQKPIIELNKHLASDPRVEIAQISIGDGVTLCRRII

[0035] Example 1: Discovery and cloning of two methylated catechin synthase genes

[0036] We performed mixed segregant transcriptome sequencing (BSR-Seq) using an F1 population constructed by hybridizing Jinxuan (JX) and Zijuan (ZJ). In the F1 population, 24 individuals with high EGCG3″Me levels (>5mg / g) and 24 individuals with low EGCG3″Me levels (<0.1mg / g) were selected to form two extreme groups. BSR-Seq analysis was performed on the IlluminaNovaSeq platform, and approximately 250,000 single nucleotide polymorphisms (SNPs) or insertions / deletions (InDels) were identified. We found that variants associated with EGCG3″Me content were enriched in a region around approximately 46Mb on chromosome 6 (GWHAZTZ00000004) of the "Huangdan" reference genome, suggesting that the target gene may be located in this region ( Figure 1 b). In addition, a total of 217 differentially expressed genes (DEGs) were identified, including 94 up-regulated DEGs and 123 down-regulated DEGs. Among the 94 up-regulated DEGs, five DEGs (HD.03G0010060, HD.03G0009980, HD.03G0009970, HD.03C0009860, HD.06002937) were putative OMTs located in the region identified on chromosome 6. RNA-seq analysis was performed on 27 tea plant accessions with significantly different genetic backgrounds to analyze the correlation between the transcript levels of 35,628 tea plant genes, including the five OMTs, and the levels of EGCG3″Me. Ultimately, we found that tea plants expressing higher levels of OMT (HD.03G0010060) generally contained more EGCG3″Me, indicating a positive correlation between them (R = 0.89, P = 2.75 × 10 -28 ).

[0037] In order to identify the candidate OMT sequences, we designed primers FAOMTF: AGTCTYATCTGRGAAAACAT (SEQ ID No. 5) and FAOMTR:

[0038] GATAACAACATTAYAAACGG (SEQ ID No. 6), the coding region was cloned from the cDNA of Jinxuan, which encodes a protein containing 236 amino acids ( Figure 2). We used the same primers to further isolate a new O-methyltransferase gene from the cDNA of Jinxuan, which was not found in any reported reference genome of tea plants. Considering that Jinxuan is also rich in EGCG4″Me, we believe that this gene may be involved in the biosynthesis of EGCG4″Me. Phylogenetic analysis of these two O-methyltransferases identified in tea plants and other different species showed that they are closely related to the flavonol and anthocyanin O-methyltransferase (FAOMT) gene in grapes ( Figure 1 c), but relatively distant from CsCCoAOMT cloned from tea plant. Therefore, these two O-methyltransferases were named CsFAOMT1 and CsFAOMT2, respectively.

[0039] Example 2: Functional verification of CsFAOMT1 and CsFAOMT2

[0040] In order to verify the functions of CsFAOMT1 and CsFAOMT2, the coding regions of CsFAOMT1 and CsFAOMT2 were fully connected to pMAL-c5x, and the recombinant expression vectors were introduced into BL21 (DE3) Escherichia coli. The two proteins were purified using maltose tag (MBP). Figure 3 ). When Mg is added exogenously 2+ Under the premise of EGCG as substrate and SAM as methyl donor, the mixture was incubated at 40℃ for 10min, and the reaction products were detected by LC-MS. Figure 4 As shown in the figure, the retention time of the substrate EGCG is 13.2min; CsFAOMT1 specifically generates product 3 with a retention time of 15.1min; CsFAOMT2 generates two products 2 and 3, with product 2 significantly more than product 3, with retention times of 14.8min and 15.1min, respectively. The mass-to-charge ratios (m / z) of the characteristic daughter ions of the two products 2 and 3 are 139, 151, 167 and 289 ( Figure 4 ). By comparing the retention time and ion fragments of the reaction product with those of EGCG4″Me and EGCG3″Me standards, it can be clearly determined that the substance at 14.8min is EGCG4″Me, and the substance at 15.1min is EGCG3″Me. The above results show that CsFAOMT1 can specifically catalyze EGCG to form EGCG3″Me, and CsFAOMT2 can specifically catalyze EGCG to form EGCG3″Me and EGCG4″Me, with EGCG4″Me being the main component.

[0041] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A methylated catechin synthase CsFAOMT2, characterized in that: Its amino acid sequence is shown in SEQ ID No.4; Or an amino acid sequence having the same protein function as the amino acid sequence shown in SEQ ID NO.4 after substitution and / or deletion and / or addition of several amino acid residues; Or an amino acid sequence derived from the amino acid sequence shown in SEQ ID No. 4, having more than 98% homology and having the same protein function.

2. The gene encoding the methylated catechin synthase CsFAOMT2 according to claim 1, characterized in that: Its nucleotide sequence is shown in SEQ ID No.3; or a DNA sequence that hybridizes with the DNA sequence shown in SEQ ID No.3 and encodes a protein with the same function; Or a DNA molecule having more than 95% homology with the DNA sequence shown in SEQ ID No.3 and encoding a protein with the same function.

3. Use of the methylated catechin synthase CsFAOMT2 as claimed in claim 1 as an O-methyltransferase.

4. Use of the methylated catechin synthase CsFAOMT2 as claimed in claim 1 in the breeding of superior tea varieties.

5. Use of the methylated catechin synthase CsFAOMT2 as claimed in claim 1 in catalyzing the conversion of EGCG into EGCG3"Me and EGCG4"Me.